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A B S T R A C T
A secondary analysis was undertaken on Scales for the Assessment of Positive and Negative Symptoms (SAPS/
SANS) data from 345 ﬁrst-episode psychosis (FEP) patients gathered in the West London FEP study. The purpose
of this study was to determine: (i) the component structure of these measures in FEP (primary analyses), and (ii)
the dependence of any ﬁndings in these primary analyses on variations in analytic methods. Symptom ratings
were exposed to data reduction methods and the eﬀects of the following manipulations ascertained: (i) level of
analysis (individual symptom vs. global symptom severity ratings), (ii) extraction method (principal component
vs. exploratory factor analysis) and (iii) retention method (scree test vs. Kaiser criterion). Whilst global ratings
level analysis rendered the classic triad of psychotic syndromes (positive, negative and disorganisation),
symptom level analyses revealed a hierarchical structure, with 11 ﬁrst-order components subsumed by three
second-order components, which also mapped on to this syndrome triad. These results were robust across data
reduction but not component retention methods, suggesting that discrepancies in the literature regarding the
component structure of the SAPS/SANS partly reﬂect the level of analysis and component retention method
used. Further, they support a hierarchical symptom model, the implications of which are discussed.
1. Introduction
Psychotic disorders represent a broad family of psychological con-
ditions that are characterised by cognitive, aﬀective, perceptual, be-
havioural, and social symptoms (American Psychiatric Association,
2013; World Health Organisation, 1992). Whilst the psychoses have
traditionally been described using a categorical approach based on di-
agnostic criteria (Parker, 2014; World Health Organization, 1992), a
number of authors have argued that psychotic disorders in fact re-
present a heterogeneous collection of phenomena (Allardyce et al.,
2007a; Bentall, 2004), with diagnostic categories demonstrating poor
validity, reliability and aetiological speciﬁcity. As an alternative di-
mensional based classiﬁcation systems posit that psychosis may be
better formulated with respect to multiple, continuous symptom
dimensions (Allardyce et al., 2007b; Van Os, 2015). This is a view that
has permeated both research and clinical practice. For example, the
latest version of the Diagnostic and Statistical Manual of Mental Dis-
orders (DSM-5) (American Psychiatric Association, 2013) carries a
rating tool called the Clinician-Rated Dimensions of Psychosis Symptom
Severity (Parker, 2014), and further, no longer includes the traditional
sub-types of schizophrenia (e.g. paranoid, disorganised, catatonic etc.)
on the basis that they lack reliability, validity and stability
(Nemeroﬀ et al., 2013). A comprehensive understanding of the under-
lying structure of psychotic symptoms is therefore critical.
Psychotic symptom dimensions are typically derived using the data
reduction methods of exploratory factor analysis (EFA) or principal
component analysis (PCA). However, there is great variability in the
number of symptom dimensions identiﬁed using these techniques
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(Peralta and Cuesta, 2001), ranging from an early ten syndrome model
(Lorr et al., 1963) to later proposals of a core triad of syndromes: reality
distortion or ‘positive’ symptoms (certain delusions and hallucinations),
psychomotor poverty or ‘negative’ symptoms (poverty of speech, lack of
spontaneous movement and aspects of blunted aﬀect) and dis-
organisation symptoms (inappropriate aﬀect, poverty of content of
speech and disturbances of the form of thought) (Liddle, 1987; Liddle
and Barnes, 1990). See Grube et al. (1998), Peralta et al. (2001) and
Smith et al. (1998) for reviews and indications of the variation in
proposed symptom models.
A number of methodological issues that might contribute to this
variability in symptom structure have been suggested (Peralta and
Cuesta, 2001; Toomey et al., 1997) including: the characteristics of the
patient sample, e.g. ﬁrst-episode or established illness, the choice of
symptom rating tool, the data reduction method, e.g. EFA or PCA, and
the method used to determine the number of factors to extract, e.g.
scree test or Kaiser criterion (eigenvector> 1) method. The choice of
symptom rating tool may be particularly critical, since scales that in-
corporate a more comprehensive list of symptoms, such as the Positive
and Negative Syndrome Scale (PANSS: van Erp et al., 2014) often
generate a greater number of symptom dimensions (Peralta and
Cuesta, 2001). For example, ﬁve factor models, which commonly in-
clude the classic triad of symptoms (positive, negative and dis-
organisation) as well as mania (/excitement/activation) and depression
(/emotional distress) are also commonly reported; see Wallwork et al.
(2012), Shafer et al. (2017) and van der Gaag et al. (2006) for example.
Another potential source of variation in the literature is the level of
analysis undertaken, i.e. what constitutes the raw material for data
reduction: individual symptom scores or scores on symptom sub-scales
(or some other composite measure/index). This is particularly relevant
for the Scales for the Assessment of Positive and Negative Symptoms
(SAPS and SANS: Andreasen, 1990), which are commonly used for
rating psychotic symptoms. The SAPS and SANS together are comprised
of 49 individual symptom items, e.g. ‘auditory hallucinations’, in ad-
dition to nine sub-scale global symptom severity summary scores, e.g.
‘global rating of hallucinations’. Whilst individual symptom level ana-
lyses of SAPS and SANS ratings typically generate around ten factors
(Minas et al., 1994; Peralta and Cuesta, 1999; Toomey et al., 1997;
Vazquez-Barquero et al., 1996), global rating level analyses generate far
fewer (typically three to four), including positive, negative and dis-
organisation syndromes (Dollfus and Petit, 1995; John et al., 2003;
Klimidis et al., 1993; Liddle, 1987; Peralta and Cuesta, 1999; Toomey
et al., 1997). Consequently, existing studies and reviews of the litera-
ture that include data from the SAPS and SANS (Grube et al., 1998;
Smith et al., 1998) may underestimate the number of psychotic
symptom dimensions as a result of the predominance of global level
analyses (Stuart et al., 1999).
One study that has the potential to resolve some of this variation in
the literature involved a symptom level PCA undertaken on SAPS and
SANS ratings from 660 inpatients with psychotic illness (Peralta and
Cuesta, 1999). This resulted in the extraction of 12 inter-correlated,
ﬁrst-order components. Critically however, the authors went on to use
these ﬁrst-order component scores as raw data for a second-order PCA;
this resulted in four second-order components, three of which accu-
rately mapped on to the positive, negative and disorganisation syn-
dromes (Liddle, 1987; Liddle and Barnes, 1990). These ﬁndings suggest
that psychotic symptoms may be inherently hierarchically structured,
with ten or more symptom clusters (Lorr et al., 1963) deﬁning a handful
of higher-level clusters (or syndromes), including Liddle's classic triad.
Taken together, these ﬁndings suggest that discrepancies in the
literature as to the dimensional structure of common psychotic
symptom measures may be driven, in part, by variations in analytic
method. Further, they suggest that some of the disparate ﬁndings re-
ported might be integrated into a two-tiered hierarchical model
(Peralta and Cuesta, 1999). To test this directly, we undertook a series
of symptom level and global rating level analyses of SAPS and SANS
scores in ﬁrst-episode psychosis (FEP). Two primary hypotheses were
tested: ﬁrst, that the derived symptom structure would depend on the
level of analysis undertaken. Speciﬁcally, we predicted that whilst a
global ratings level analysis would lead to the extraction of the classic
triad of syndromes, symptom level analysis would generate approxi-
mately ten ﬁrst-order components. Second, we predicted, that in sup-
port of Peralta and Cuesta's (1999) hierarchical symptom model, it
would be possible to recover the classic triad of syndromes by under-
taking a second-order symptom level analysis. Finally, in order to ex-
plore how diﬀerent statistical approaches may have shaped dis-
crepancies in the literature as to the underlying structure of the SAPS
and SANS, we also explored the dependence of any ﬁndings on common
variations in method of data reduction or component retention (Peralta
and Cuesta, 2001; Toomey et al., 1997).
2. Methods
2.1. Setting
The data were collected as part of the prospective West London
First-Episode Psychosis study (WLFEP: Barnes et al., 2000; Joyce et al.,
2005). Participants had presented to secondary care services within the
London boroughs of Ealing, Hammersmith and Fulham, Wandsworth,
Kingston, Richmond, Merton, Sutton and Hounslow, between 1998 and
2006. Ethical approval was obtained from local ethics committees of all
boroughs included and written informed consent was obtained.
2.2. Participants
Patients were deemed eligible for inclusion in the study if they were
resident in London (deﬁned as any borough within the M25), aged 16
years or older, experiencing a ﬁrst psychotic episode (aﬀective or non-
aﬀective), had received fewer than 12 weeks of antipsychotic medica-
tion and had suﬃcient command of the English language to facilitate
assessment. Potential participants were initially screened for a psy-
chotic disorder using the World Health Organization Psychosis Screen
(Jablensky et al., 1992). Where a psychotic disorder was indeed in-
dicated, a full diagnosis was derived using a comprehensive structured
interview known as the diagnostic module of the Diagnostic Interview
for Psychosis (Castle et al., 2006), which includes items from the World
Health Organization Schedules for Clinical Assessment in Neu-
ropsychiatry (SCAN; Wing et al., 1990) and the Operational Criteria
Checklist for Psychosis (OPCRIT; McGuﬃn et al., 1991). Information
derived from this interview was then fed into a computer algorithm
(MRC Social Genetic and Dev Psychiatry Centre, n.d.) to generate di-
agnoses according to multiple classiﬁcation systems including the Di-
agnostic and Statistical Manual of Mental Disorders (3rd ed.; DSM-III;
American Psychiatric Association, 1980) and subsequently converted
into DSM-IV categories by cross-referencing with DSM-IV criteria
(American Psychiatric Association, 1994). These screening and diag-
nostic assessment stages were undertaken by two psychiatric research
nurses (IH and SM) trained in the administration of relevant tools by a
highly experienced psychiatrist (TB). See Huddy et al. (2007) also.
2.3. Data collection
Information was obtained, with informed consent, from partici-
pants’ clinical records and clinical interview, as well as interviews with
participants’ carers and relatives, where possible. Data gathered at the
time of ﬁrst presentation to services included basic demographic in-
formation, as well as performance on an array of clinical, cognitive and
neuropsychological assessments. All researchers involved in data col-
lection (the two research nurses mentioned above and a graduate re-
search psychologist) received training to a high standard in the appli-
cation of these measures. Data on ethnicity were not gathered routinely.
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2.4. Measures
Psychotic symptoms were assessed using the SAPS and SANS
(Andreasen, 1990), which were administered with an inter-rater relia-
bility of ≥ 0.77 by IH and SM. The SAPS is a 34-item clinician-ad-
ministered questionnaire, which divides symptoms into four sub-scales
(hallucinations, delusions, bizarre behaviour and formal thought dis-
order), each of which is also given a global symptom severity score by
the rater (global ratings). It is therefore comprised of 30 individual
symptom ratings and four global ratings. The SANS is a 24-item clin-
ician-administered questionnaire, which divides symptoms into ﬁve
sub-scales (aﬀective ﬂattening or blunting, alogia, avolition-apathy,
anhedonia-asociality, attention), also given global ratings. It is there-
fore comprised of 19 individual symptom ratings and ﬁve global rat-
ings. The measures have been validated in recent-onset psychosis
(Fulford et al., 2014) and correlate well with other symptom measures,
e.g. the PANSS (r=0.71–0.84) (van Erp et al., 2014).
2.5. Analyses
All analyses were undertaken using SPSS (version 22; SPSS Inc.,
Chicago, IL). In order to determine data factorability, data were as-
sessed for suﬃcient correlation between items, excessively large inter-
item correlations (r>0.9), sphericity (Bartlett's test) and sampling
adequacy (Kaiser, 1974)/anti-image correlation matrix diag-
onals> 0.5. Any failure to meet these checks are reported in the text.
In a global ratings level analysis the nine global ratings of the SAPS
and SANS were exposed to a PCA following the methods described by
John et al. (2003). Principal components were extracted if they had an
eigenvector value> 1 using a VARIMAX rotation, leading to the ex-
traction of orthogonal components.
In a symptom level analysis individual symptom item scores were
exposed to a two-step analytic approach following the methods of
Peralta and Cuesta (1999). The ﬁrst-order PCA was ﬁrst undertaken on
all 49 individual symptom SAPS and SANS scores, followed by a second-
order PCA on the principal component scores extracted from this ﬁrst-
order analysis.
For the ﬁrst-order analysis, principal components were extracted if
they had an eigenvector value>1 using the OBLIMIN oblique rotation,
since correlations were expected between symptom dimensions at this
stage of analysis (Peralta et al., 1997). The second-order PCA was un-
dertaken on principal component scores extracted from the ﬁrst-order
analysis using a VARIMAX rotation.
For all analyses undertaken individual items were retained/deemed
to belong to an extracted dimension if they exhibited a loading of 0.4 or
greater.
In order to assess the dependence of any ﬁndings on analytic ap-
proach all analyses were re-run using alternative methods of data re-
duction (whilst retaining dimensions using the Kaiser criterion
method). Choices as to which methodological variants to include were
made on the basis of the most common analyses adopted in the existing
literature. This was because our intention was to explore the possible
impact of these on reported ﬁndings rather than to undertake an ex-
haustive review of all possible statistical approaches. Thus, in addition
to using the Kaiser criterion to deﬁne the number of factors to extract
the scree method was also assessed. The eﬀects of running EFA as an
alternative to PCA was also explored. Four diﬀerent estimation methods
were used with the EFA: principle axis factoring, unweighted least
squares, generalised least squares and maximum likelihood.
Finally, since a number of researchers have argued that the
‘Attention’ subscale should be excluded a priori from the SANS on the
basis that attention is a neurocognitive domain, e.g. Blanchard and
Cohen (2006), the primary PCAs were re-run without these subscale
items. Since these analyses did not generate substantially diﬀerent
ﬁndings these data are presented in Supplementary Tables and dis-
cussed in brief only.
3. Results
3.1. Missing data and sample characteristics
Information as to the number of potential participants that were
evaluated, screened and excluded was not routinely recorded
throughout the study; consequently, these data are not available.
Ultimately however, 345 participants met criteria for inclusion. Of
these 345 full symptom data-sets (complete SAPS/SANS scores) were
available for 335 cases; this formed the basis of all PCAs and EFAs re-
ported (complete case analyses). Several additional variables are also
reported for the patient sample, e.g. Age of Onset and Duration of
Untreated Psychosis (Table 1). Whilst a number of individual cases
were missing for these additional variables, with the exception of IQ
(see below), this loss represented a small proportion of the total number
of cases (< 3%).
Participant characteristics are presented in Table 1, including the
duration of untreated psychosis (DUP), calculated using the Not-
tingham Onset Scale (NOS) (Singh et al., 2005), socioeconomic status,
deﬁned on the basis of participant occupation using the National Sta-
tistics Socio-Economic Classiﬁcation system (NS-SEC) (Rose and
Pevalin, 2005) and premorbid IQ, assessed using the National Adult
Reading Test (NART) (Lezak, 2004; Nelson and Wilson, 1991). The
median age at assessment was 24.07 years with an inter-quartile range
(IQR) of 20–30.13, the median age at onset was 23 years
(IQR=19–28), and the median DUP was 12 weeks (IQR=4–45). With
respect to socioeconomic status the vast majority of participants were
unemployed (189 of 332 participants for whom these data were
available). The majority of participants were recorded as having a di-
agnosis of non-aﬀective psychosis (255 of 329 participants for whom
these data were available) as opposed to an aﬀective psychosis
(n=74). With respect to symptom severity, the median SAPS total
Table 1
Demographic and clinical characteristics of the study sample. Statistics pro-
vided include the number of cases (N), the median and the inter-quartile range
(IQR). Data are provided for the complete-case analysis data-set, i.e. partici-
pants for whom full symptom data were available (N=335). Missing data (n/
%) indicate the number and percentage of cases missing relative to this data-set.
DUP=duration of untreated psychosis; NS-SEC=National Statistics Socio-
Economic Classiﬁcation system; SAPS=Scales for the Assessment of Positive
symptoms; SANS=Scales for the Assessment of Negative symptoms;
NART=National Adult Reading Test.
Variable Level N Missing
(n/%)
Median IQR
Age at Assessment
(years)
– 334 1 (0.29%) 24.07 20–30.13
Age at Onset (years) – 326 9 (2.69%) 23 19–28
DUP (weeks) – 330 5 (1.49%) 12 4–45
Gender All 333 2 (0.6%) – –
Male 218 – – –
Female 115 – – –
NS-SEC All 332 3 (0.9%) – –
Managerial and
professional
18 – – –
Intermediate
occupations
22 – – –
Routine and
manual
51 – – –
Student 52 – – –
Unemployed 189 – – –
Diagnosis All 329 6 (1.79%) – –
Aﬀective 74 – – –
Non-aﬀective 255 – – –
SAPS total – 335 0 (0%) 32 23–45
SANS total – 335 0 (0%) 18 7–34
NART – 267 68
(20.3%)
97 87–107
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score was 32 (IQR=23–45) and the median SANS total score was 18
(IQR=7–34). Finally, the median IQ score was 97 (IQR=87–107),
although these data were only available for a small section of the
sample (n=267); nonetheless, these data are presented to facilitate
comparison with previous published studies.
3.2. Global ratings level analysis
PCA of SAPS and SANS global ratings resulted in the extraction of
three components with eigenvectors> 1; these explained 63.7% of the
variance. Examination of the associated scree plot (see Fig. 1) indicated
that if the scree test were used to determine the number of factors
(instead of the Kaiser criterion method) the ﬁndings would be identical.
Extracted components mapped on to the classic triad of symptoms.
Table 2 shows the component loadings. (See supplementary Table 1
also for the component score coeﬃcient matrix). The ﬁrst component
(negative symptoms), which explained 34.3% of the variance in the
data was comprised of loadings from aﬀective ﬂattening, alogia, avo-
lition/apathy, anhedonia/asociality and attention. The second compo-
nent (disorganisation symptoms), which explained 16% of the variance
in the data, was comprised of loadings from delusions, bizarre beha-
viour and positive formal thought disorder. Finally, the third compo-
nent (positive symptoms), which explained 13.5% of the variance in the
data, was comprised of loadings from hallucinations and delusions.
Highly similar results were obtained using EFA instead of PCA, ir-
respective of which extraction method was used, i.e. principle axis
factoring, unweighted least squares, generalised least squares or max-
imum likelihood (see Table 2). The primary diﬀerence was that load-
ings were consistently lower for the EFAs than for PCA, a consequence
of which is that several items just failed to reach the threshold for in-
clusion on some components, e.g. delusions on the disorganisation
symptoms component (seen across all EFAs), and hallucinations on the
positive symptoms component (seen in the maximum likelihood
method only).
3.3. First-order symptom level analysis
Next, a PCA was undertaken on SAPS and SANS individual item
scores. Three of the values on the diagonals of the anti-image
Fig. 1. Scree plot for components identiﬁed in the global ratings level principal
component analysis. Component numbers are plotted against the scaled ei-
genvalues for each eigenvector (eigenvalue divided by the total number of
components). The dotted line represents the eigenvector> 1 line (i.e. 1 divided
by the total number of components).
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correlation matrix were<0.5, indicating items that did not share suf-
ﬁcient variance with other items to warrant inclusion. Consequently,
these three items (persecutory delusions, delusions of sin or guilt and
somatic delusions) were excluded and the analysis was rerun without
them, i.e. using 46 of the full 49 individual symptom ratings.
The ﬁrst-order symptom level PCA resulted in the extraction of 11
components with eigenvectors> 1, which together explained 63.2% of
the variance in the data. In contrast, it was not clear how many com-
ponents should be extracted on the basis of the scree test since there
was no clearly deﬁned inﬂection point (see Fig. 2), and arguably, two
inﬂection points: one that would lead to the extraction of∼four or ﬁve
components, and one that would lead to ∼11 or 12. Thus, the two
methods of component retention produce highly divergent results in
this example, since retention of the ﬁrst four or ﬁve components would
exclude most of the positive symptoms of psychosis (most of the hal-
lucinations and delusions for example).
Table 3 shows the associated PCA structure with variable loadings.
The 11 components extracted were named: (i) negative symptoms, (ii)
thought disorder, (iii) delusions, (iv) social dysfunction, (v) bizarre
behaviour, (vi) auditory hallucinations, (vii) grandiose and religious
delusions, (viii) other hallucinations (ix) delusions of jealousy (com-
prised of a single item only), (x) alogia and inattentiveness, and (xi)
other bizarre behaviour.
Additional analyses were undertaken to determine the eﬀects of
using EFA as opposed to PCA (Supplementary Tables 2–5). Since the
models would not converge (within 9999 iterations) using oblique ro-
tation methods (OBLIMIN or PROMAX), an orthogonal rotation (VAR-
IMAX) was used instead. This was not planned for a priori, and it is not
clear why convergence did not occur: communalities were all < 1,
ruling out the possibility of a Heywood Case, and all tests of data fac-
torability were passed.
The main ﬁndings were highly robust, particularly for the lower
numbered components with multiple loadings, which showed high
consistency across EFA methods and only minor diﬀerences in their
ordering. For example, negative symptoms, thought disorder, social
dysfunction and delusions consistently emerged as the ﬁrst four com-
ponents, with negative symptoms consistently the ﬁrst to be extracted,
thought disorder consistently the second, and social dysfunction and
delusions variably extracted third and fourth, or fourth and third,
respectively. Other minor diﬀerences were due to individual items
failing to cross the >0.4 inclusion threshold, as well as the relative
instability of components with few item loadings.
Finally, see Supplementary Table 6 for details on the eﬀects of re-
running the ﬁrst-order PCA without items relating to the Attention
subscale. Eleven components were again extracted, which together
explained 63.9% of the variance. These were suﬃciently similar in their
pattern of item loadings that the ﬁrst nine components extracted were
labelled identically to the basic PCA (see Supplementary Table 7 also).
Components ten and 11 also showed similarities across analyses, but
were reversed in their relative ordering. Fundamentally therefore, re-
moval of items relating to attention had very little impact on the pattern
of ﬁndings.
3.4. Second-order symptom level analysis
Next a second-order PCA was undertaken on the component scores
to have emerged from the ﬁrst-order symptom level analysis. Three
components were extracted with eigenvectors > 1, explaining 41.5% of
the variance. Examination of the associated scree plot (Fig. 3), indicated
that use of the scree test resulted in identical ﬁndings.
Table 4 (columns 1–4) shows the associated PCA structure with
variable loadings. The ﬁrst component (negative symptoms), which
explained 16.4% of the variance, showed loadings from the negative
symptoms, social dysfunction and alogia and inattentiveness compo-
nents derived from the ﬁrst-order PCA. The second component (positive
symptoms), which explained 13.3% of the variance, showed loadings
from delusions, auditory hallucinations and other hallucinations. The
third component (disorganisation symptoms), which explained 11.7%
of the variance, showed loadings from thought disorder, bizarre beha-
viour, grandiose and religious delusions and other bizarre behaviours.
Use of EFA instead of PCA (Table 4 columns 5–16) resulted in three
highly similar factors that could also be labelled negative, positive and
disorganisation symptoms. The main diﬀerences between the PCA and
EFAs was that in the latter, the positive symptoms factor did not include
a loading from other hallucinations and the negative symptoms factor
did not include a loading from social dysfunction; this was consistent
across factor analytic methods used. Further, in the EFAs the dis-
organisation symptom factor was uniquely associated with symptoms of
thought disorder, i.e. there were no signiﬁcant loadings from bizarre
behaviour and grandiose/religious delusions.
Finally, see Supplementary Table 7 for details on the eﬀects of re-
running the second-order PCA using the output of the ﬁrst-order ana-
lysis which did not include items relating to the Attention subscale.
Once again, the ﬁndings were very similar to those reported when items
relating to attention were retained. Three components were again ex-
tracted, which together explained 40.9% of the variance. These were
labelled negative, positive and disorganisation components, and ex-
hibited a near identical pattern of item loadings to the basic PCA.
4. Discussion
Consistent with hypothesis one (dependence on level of analysis),
the data suggest that whilst symptom level analysis of the SAPS and
SANS results in ten+ inter-correlated ﬁrst-order components, global
ratings level analysis results in a three component solution
(Toomey et al., 1997). The ﬁndings also support the robustness of the
triadic syndrome model (Grube et al., 1998; Smith et al., 1998). Thus,
positive, negative and disorganisation symptom dimensions emerged
from analyses of SAPS and SANS global ratings as well as second-order
analyses of individual item ratings, irrespective of data reduction and
component retention method.
Consistent with hypothesis two (hierarchical symptom structure)
the ﬁndings also support a complex hierarchical structure to the
symptom data, with the aforementioned 10+ ﬁrst-order factors being
subsumed by three-to-four second-order factors (Peralta and
Fig. 2. Scree plot for components identiﬁed in the ﬁrst-order individual
symptom level principal component analysis. Component numbers are plotted
against the scaled eigenvalues for each eigenvector (eigenvalue divided by the
total number of components). The dotted line represents the eigenvector> 1
line (i.e. 1 divided by the total number of components).
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Cuesta, 1999). Infact, the ﬁndings are remarkably similar to those re-
ported by Peralta and Cuesta (1999); this, despite a considerable dif-
ference in population sample (ﬁrst-episode versus multi-episode psy-
chosis), a fact that points to the robustness of the ﬁndings/symptom
structure revealed. Thus, whilst Peralta and Cuesta (1999) reported 12
ﬁrst-order components, which explained 66% of the variance, we report
11 ﬁrst-order components, which explain 63%, the ﬁrst four of which
were nearly identical across studies. The two sets of studies also ren-
dered highly similar, second-order components, with Peralta and
Cuesta (1999) reporting four second-order dimensions, which explained
54% of the variance, where we report three, which together explained
41%. Whilst the ﬁrst three components mapped on to the classic triad of
syndromes (positive, negative and disorganisation), the fourth compo-
nent identiﬁed by Peralta and Cuesta (1999) was comprised of a single
loading only (‘other delusions’).
Whilst a minority of the ﬁrst-order components identiﬁed could be
mapped almost directly onto SAPS and SANS global rating sub-scales,
e.g. component two (thought disorder), other components identiﬁed
either split or cut across categories with loadings from across multiple
sub-scales, e.g. component six (auditory hallucinations), which
included items from the hallucinations sub-scale (including auditory
hallucinations) as well as the delusions subscale (thought broad-
casting). This lack of direct correspondence is perhaps not surprising
given that the nine global rating sub-scales of the SAPS/SANS were in
fact generated on the basis of clinical opinion and subjective experience
(Andreasen, 1990; Andreasen and Olsen, 1982). This questions the
validity of the SAPS and SANS sub-scales and has led some to call for
their re-structuring along more empirically-deﬁned lines (de Leon et al.,
1993; Keefe et al., 1992; Vazquez-Barquero et al., 1996).
4.1. Dependence on component number estimation method
Whilst the same core symptom structure was revealed across ana-
lyses the choice of component retention method did have some impact
on ﬁndings (scree test versus Kaiser criterion method). Whilst the two
techniques rendered identical results for the global ratings and second-
order symptom level analyses, ﬁndings for the ﬁrst-order symptom level
analysis were less stable. The scree test did not yield a deﬁnitive
number of components: inﬂection points were multiple and ambiguous;
see Ledesma (2007) and Zwick and Velicer (1986) for discussion. One
Table 3
Component loadings (structure) matrix for all 46 items included in the ﬁrst-order principal component analysis. Loadings> 0.4 in magnitude are shown in bold.
Note: three items of the original 49 were excluded as they did not meet assumptions of the analysis.
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11
% variance explained 19.4 9.4 9.1 5 3.8 3.4 3 2.8 2.5 2.4 2.3
Hallucinations SAPS-H1 Auditory 0.03 −0.08 0.29 −0.10 −0.09 −0.81 0.04 0.23 −0.09 0.04 0.10
SAPS-H2 Voices commenting 0.07 −0.01 0.29 −0.15 −0.04 −0.84 0.01 0.23 0.08 0.01 −0.03
SAPS-H3 Voices conversing 0.08 −0.03 0.27 −0.09 −0.09 −0.82 −0.09 0.14 0.06 0.05 −0.02
SAPS-H4 Somatic or tactile −0.12 −0.02 0.17 −0.03 −0.36 −0.38 −0.25 0.45 0.11 0.07 −0.08
SAPS-H5 Olfactory −0.02 0.02 0.30 −0.06 0.03 −0.14 −0.03 0.72 0.11 0.01 0.00
SAPS-H6 Visual 0.01 0.03 0.14 −0.01 −0.08 −0.28 −0.04 0.75 0.03 −0.02 0.00
Delusions SAPS-D2 Jealous −0.02 −0.05 0.14 0.01 0.06 −0.04 0.03 0.12 0.77 −0.01 −0.06
SAPS-D4 Grandiose −0.15 0.21 0.10 0.12 0.30 0.01 −0.69 0.01 0.07 −0.06 −0.08
SAPS-D5 Religious −0.07 0.03 0.14 0.09 −0.09 −0.01 −0.79 0.05 −0.09 −0.04 −0.03
SAPS-D7 Of reference 0.00 0.02 0.45 −0.14 −0.10 −0.25 −0.25 −0.05 0.33 0.13 0.34
SAPS-D8 Of being controlled 0.04 0.07 0.65 −0.11 −0.25 −0.22 −0.32 0.21 0.05 0.15 0.03
SAPS-D9 Of mind reading 0.05 0.11 0.69 −0.05 −0.11 −0.17 −0.13 0.10 0.25 0.11 0.08
SAPS-D10 Thought broadcasting 0.05 0.07 0.72 −0.05 0.03 −0.43 −0.09 0.22 0.13 0.19 −0.01
SAPS-D11 Thought insertion 0.10 −0.04 0.72 −0.03 −0.07 −0.32 −0.09 0.20 0.00 0.05 −0.10
SAPS-D12 Thought withdrawal 0.13 0.12 0.76 −0.08 −0.01 −0.20 −0.01 0.28 0.01 −0.03 −0.06
Bizarre behaviour SAPS-B1 Appearance −0.09 0.11 −0.14 0.05 0.33 −0.09 −0.34 −0.07 0.05 −0.06 −0.59
SAPS-B2 Social/sexual 0.05 0.19 0.00 0.03 0.51 0.10 −0.42 0.16 0.03 0.08 −0.18
SAPS-B3 Aggressive/agitated −0.02 0.01 −0.10 0.07 0.77 0.06 −0.01 −0.08 0.02 0.03 −0.08
SAPS-B4 Repetitive/stereotyped 0.16 0.13 0.30 −0.05 −0.19 0.14 0.00 0.25 0.07 0.19 −0.52
Formal thought disorder SAPS-P1 Derailment 0.12 0.85 0.10 −0.15 0.01 0.04 −0.07 0.02 −0.02 0.29 −0.13
SAPS-P2 Tangentiality 0.15 0.83 0.05 −0.24 −0.02 0.01 −0.05 −0.05 0.06 0.31 −0.16
SAPS-P3 Incoherence 0.13 0.46 0.15 −0.13 0.10 −0.05 0.01 −0.09 0.02 0.15 −0.57
SAPS-P4 Illogicality 0.19 0.79 0.18 −0.24 0.10 0.05 −0.04 0.10 −0.05 0.24 −0.19
SAPS-P5 Circumstantiality 0.17 0.77 0.15 −0.21 −0.03 0.00 −0.18 0.03 −0.02 0.16 −0.09
SAPS-P6 Pressure of Speech −0.19 0.59 −0.20 0.04 0.25 0.20 −0.21 −0.02 −0.08 −0.20 −0.21
SAPS-P7 Distractible Speech 0.03 0.61 0.06 −0.03 0.35 0.04 −0.06 0.08 −0.24 0.24 −0.08
SAPS-P8 Clanging 0.10 0.61 0.16 −0.15 0.19 0.07 −0.02 0.30 −0.31 0.00 −0.12
Aﬀective ﬂattening/blunting SANS-1 Facial expression 0.88 0.09 0.08 −0.37 −0.06 −0.02 0.14 −0.05 −0.09 0.32 −0.03
SANS-2 Spontaneous movements 0.86 0.12 0.13 −0.27 −0.07 −0.07 0.05 −0.02 −0.13 0.19 −0.09
SANS-3 Expressive gestures 0.93 0.12 0.06 −0.36 −0.03 0.00 0.09 −0.01 −0.10 0.28 −0.07
SANS-4 Eye contact 0.56 0.04 0.01 −0.24 0.09 −0.06 0.08 0.01 −0.08 0.37 −0.29
SANS-5 Non-responsiveness 0.87 0.17 0.13 −0.35 0.07 −0.02 0.13 0.07 −0.02 0.29 −0.11
SANS-7 Vocal Inﬂections 0.87 0.05 0.15 −0.36 0.02 −0.08 0.12 0.02 −0.02 0.30 −0.10
Alogia SANS-9 Poverty of speech 0.72 −0.07 0.00 −0.19 0.05 −0.11 0.22 0.03 −0.15 0.57 0.00
SANS-10 Poverty of speech content 0.36 0.52 0.01 −0.23 −0.05 0.07 0.00 0.05 −0.09 0.53 −0.12
SANS-11 Blocking 0.55 0.26 0.26 0.03 0.07 0.02 0.15 0.15 −0.12 0.64 −0.01
SANS-12 Latency of response 0.68 0.18 0.12 −0.04 0.05 −0.08 0.10 0.06 −0.19 0.61 0.04
Avolition/apathy SANS-14 Grooming/hygiene 0.34 0.13 0.00 −0.53 0.26 −0.05 −0.07 −0.09 −0.36 0.27 −0.43
SANS-15 Impersistence 0.23 0.24 0.11 −0.68 0.23 −0.09 −0.11 −0.02 −0.17 0.25 0.04
SANS-16 Physical anergia 0.52 0.14 0.16 −0.63 −0.06 −0.15 0.02 0.00 −0.34 0.27 −0.06
Anhedonia/asociality SANS-18 Recreational interest/ activity 0.35 0.10 0.08 −0.70 −0.19 −0.20 0.21 −0.03 −0.19 0.18 −0.01
SANS-19 Sexual interest/activity 0.25 0.08 0.03 −0.64 −0.25 −0.15 0.09 0.15 0.00 −0.04 0.04
SANS-20 Ability to feel intimacy 0.31 0.18 0.12 −0.75 −0.06 −0.04 0.19 0.04 0.21 0.20 −0.17
SANS-21 Relationships 0.45 0.24 0.06 −0.81 −0.02 −0.05 0.16 0.07 0.14 0.32 −0.08
Attention SANS-23 Social inattentiveness 0.29 0.35 0.13 −0.45 0.10 0.00 0.02 −0.04 −0.02 0.73 −0.16
SANS-24 Inattentiveness during testing 0.39 0.44 0.04 −0.39 0.10 0.02 0.03 −0.02 −0.09 0.66 −0.29
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possible inﬂection point would have yielded a comparable number of
components to the Kaiser criterion method (∼11 or 12), whilst the
other would have yielded far fewer (∼four or ﬁve). The choice of re-
tention method thus has profound implications on the ﬁndings since the
exclusive retention of the ﬁrst four components would result in the loss
of all information relating to hallucinations as well as a subset of de-
lusions (see Table 3). This would seem to represent an unjustiﬁable loss
of information from a clinical perspective. In contrast, retention of the
full 11–12 components (e.g. as indicated by the Kaiser criterion
method) would result in the inclusion of components with few item
loadings (sometimes only one, e.g. Table 3 component 9), or compo-
nents that combine seemingly unrelated symptoms that make little
sense clinically (e.g. Table 3, component 7).
The ﬁndings therefore support the notion that discrepancies in the
literature as to the precise number of psychotic components may be
driven, in part, by diﬀerences in the methods used to determine the
number of factors. Further, they are consistent with Peralta and
Cuesta's (2001) review of the literature, which found that the use of the
scree method consistently resulted in the extraction of around half the
number of dimensions rendered by the Kaiser criterion method.
4.2. Dependence on data reduction method
The choice of data reduction method did not impact drastically
upon the ﬁndings. PCA and EFA generated near-identical results in the
global ratings and symptom level analyses. There was, however, a
consistent trend for lower loadings using EFA relative to PCA, with
several items failing to reach the threshold for inclusion as a result.
Peralta and Cuesta similarly concluded that the core structure un-
derlying psychotic symptoms (as revealed by common symptom mea-
sures) is relatively robust to changes in data reduction method. They
found near-identical eﬀects of using EFA (with principal axis factoring)
or PCA to analyse SAPS and SANS data in a sample of 660 patients with
psychosis (Peralta and Cuesta, 1999), and further, in a review of the
literature noted robust factor solutions across a range of studies using
diﬀerent data reduction methods (Peralta and Cuesta, 2001).
Fig. 3. Scree plot for components identiﬁed in the second-order symptom level
principal component analysis. Component numbers are plotted against the
scaled eigenvalues for each eigenvector (eigenvalue divided by the total
number of components). The dotted line represents the eigenvector> 1 line
(i.e. 1 divided by the total number of components).
Ta
bl
e
4
C
om
po
ne
nt
/
fa
ct
or
lo
ad
in
gs
(r
ot
at
ed
m
at
ri
x)
fo
r
al
l1
1
va
ri
ab
le
s
in
cl
ud
ed
in
th
e
se
co
nd
-o
rd
er
an
al
ys
es
.T
he
co
eﬃ
ci
en
ts
of
co
m
po
ne
nt
s
4,
6,
7
an
d
11
ha
ve
be
en
in
ve
rt
ed
to
ai
d
in
te
rp
re
ta
ti
on
.T
hi
s
is
ap
pr
op
ri
at
e,
si
nc
e
in
th
e
ﬁ
rs
t-
or
de
r
PC
A
th
e
lo
ad
in
gs
as
so
ci
at
ed
w
it
h
th
es
e
fo
ur
co
m
po
ne
nt
s
w
er
e
ne
ga
ti
ve
,i
.e
.o
f
a
di
ﬀ
er
en
t
si
gn
to
th
e
ot
he
r
co
m
po
ne
nt
s.
Lo
ad
in
gs
>
0.
4
in
m
ag
ni
tu
de
ar
e
sh
ow
n
in
bo
ld
.
Pr
in
ci
pa
l
C
om
po
ne
nt
A
na
ly
si
s
Pr
in
ci
pa
l
A
xi
s
Fa
ct
or
in
g
U
nw
ei
gh
te
d
Le
as
t
Sq
ua
re
s
G
en
er
al
is
ed
Le
as
t
Sq
ua
re
s
M
ax
im
um
Li
ke
lih
oo
d
N
EG
PO
S
D
IS
N
EG
PO
S
D
IS
N
EG
PO
S
D
IS
N
EG
D
IS
PO
S
N
EG
PO
S
D
IS
%
va
ri
an
ce
ex
pl
ai
ne
d
16
.4
13
.3
11
.7
16
.4
13
.3
11
.7
16
.4
13
.3
11
.7
16
.4
13
.3
11
.7
16
.4
13
.3
11
.7
(1
)
N
eg
at
iv
e
Sy
m
pt
om
s
0.
78
−
0.
02
−
0.
01
0.
78
−
0.
01
−
0.
03
0.
78
−
0.
01
−
0.
03
0.
87
−
0.
05
−
0.
01
0.
87
−
0.
02
−
0.
05
(2
)
Th
ou
gh
t
D
is
or
de
r
0.
29
0.
04
0.
62
0.
20
0.
05
0.
54
0.
20
0.
05
0.
54
0.
17
0.
81
0.
02
0.
16
0.
04
0.
74
(3
)
D
el
us
io
ns
0.
16
0.
72
0.
05
0.
12
0.
63
0.
05
0.
12
0.
63
0.
05
0.
12
0.
07
0.
62
0.
13
0.
63
0.
06
(4
)
So
ci
al
dy
sf
un
ct
io
n
0.
63
0.
10
0.
00
0.
40
0.
09
0.
06
0.
40
0.
09
0.
06
0.
37
0.
11
0.
09
0.
37
0.
08
0.
11
(5
)
Bi
za
rr
e
be
ha
vi
ou
r
−
0.
08
−
0.
25
0.
57
−
0.
03
−
0.
16
0.
29
−
0.
03
−
0.
16
0.
29
0.
00
0.
16
−
0.
17
0.
00
−
0.
16
0.
19
(6
)
A
ud
it
or
y
ha
llu
ci
na
ti
on
s
0.
09
0.
62
−
0.
17
0.
06
0.
41
−
0.
12
0.
06
0.
41
−
0.
12
0.
04
−
0.
10
0.
43
0.
05
0.
41
−
0.
12
(7
)
G
ra
nd
io
se
an
d
re
lig
io
us
de
lu
si
on
s
−
0.
34
0.
32
0.
51
−
0.
18
0.
17
0.
25
−
0.
18
0.
17
0.
25
−
0.
15
0.
16
0.
15
−
0.
15
0.
15
0.
17
(8
)
O
th
er
ha
llu
ci
na
ti
on
s
0.
00
0.
57
0.
09
0.
02
0.
33
0.
04
0.
02
0.
33
0.
04
0.
02
0.
05
0.
33
0.
02
0.
33
0.
04
(9
)
Je
al
ou
s
de
lu
si
on
s
−
0.
22
0.
29
−
0.
11
−
0.
12
0.
15
−
0.
07
−
0.
12
0.
15
−
0.
07
−
0.
13
−
0.
06
0.
16
−
0.
13
0.
16
−
0.
06
(1
0)
A
lo
gi
a
an
d
in
at
te
nt
iv
en
es
s
0.
64
0.
06
0.
17
0.
45
0.
07
0.
16
0.
45
0.
07
0.
16
0.
42
0.
15
0.
08
0.
42
0.
08
0.
16
(1
1)
O
th
er
bi
za
rr
e
be
ha
vi
ou
r
0.
12
−
0.
02
0.
55
0.
10
−
0.
02
0.
28
0.
10
−
0.
02
0.
28
0.
10
0.
19
−
0.
03
0.
10
−
0.
03
0.
21
M.S. Tibber et al. Psychiatry Research 270 (2018) 869–879
875
4.3. Model utility and validity
The data reported strongly suggest that a simple dichotomy between
positive and negative symptoms, which underlies the construction of
the SAPS and SANS, does a poor job of capturing the full complexity of
the underlying symptom structure. Thus, at the very least, it is clear that
the symptoms of disorganisation cannot be lumped together on either
positive or negative dimensions, but instead, represent a distinct syn-
drome or cluster; see discussion in Dazzi et al. (2016) for example.
Beyond this, however, it is not clear which level of description de-
scribed here oﬀers the most useful account of psychotic symptom
structure: the ﬁrst-order model, which describes 10+ dimensions, re-
taining much of the complexity of the original data-set, or a higher-
order (more parsimonious) model based on the classic triad of positive,
negative and disorganisation symptoms. To address this question as it
related to their own data, Peralta and Cuesta (1999) turned to the
amount of variance explained by each level of the model (ﬁrst-order
and second-order). Thus, whilst the data reported here show that the 11
ﬁrst-order components accounted for 63.1% of the variance in the 46
symptoms included in the model, the three second-order components
accounted for 41.5% of the ﬁrst-order components. This implies that
the second-order components only accounted for 26.2% of the variance
in individual SAPS/SANS scores (41.5% of 63.2%). This represents a
considerable loss of variance, and suggests that the positive, negative
and disorganisation symptom clusters, by themselves, do a relatively
poor job of capturing the full richness of psychotic symptoms.
This trade-oﬀ between parsimony and completeness of description
is inevitable, however, and the relative utility of each model will de-
pend on the purpose/s for which they are being used. One might argue,
therefore, that clinical/professional judgement should play a crucial
role in deciding how many -and which- components should be retained,
although this would inevitably introduce a further stage of subjectivity
to the analyses. For example, a measure/model that is used in a clinical
context, should be of clinical utility, able to assist in the processes of
assessment, treatment and outcome monitoring. One might question,
for example, to what extent component nine in the ﬁrst-order item-level
analysis (comprised of a single item: delusions of jealousy) adds any-
thing of clinical utility to the model (Table 3). In contrast, models
employed in research may require a distinct set of utilities, although
there may be some overlap, particularly where research is applied and
of direct clinical relevance.
With this in mind, the triadic symptom model is robust, highly re-
producible (including across diﬀerent measures) and, with only three
scores to deﬁne it, easy to manage with good face validity (Grube et al.,
1998; Smith et al., 1998). For research purposes, such as the in-
vestigation of associations between symptom dimensions and deﬁned
risk factors, clinical outcomes and treatment eﬀects can be tested and
interpreted without a large inﬂation in the risk of a type one error
(Allardyce et al., 2007a; Oher et al., 2014; Wickham et al., 2014), as
would be the case if a more complex multi-dimensional model were
used. However, this loss of information inevitably risks missing patterns
of association operating at a ﬁner scale of analysis, e.g. between risk
factors and individual symptoms. (Note: a similar discussion in the
literature has arisen around the beneﬁts versus costs and trade-oﬀs
involved in using longer versus shorter versions of common symptom
measures such as the PANSS; see Lindenmayer (2017) and Lin et al.
(2018) for example.)
If a system of symptom classiﬁcation is to be truly valid, however,
one might argue that its structure should reﬂect something meaningful
about the aetiology, course or treatment-responsiveness of symptoms
(for example), rather than mere statistical artefact. In support of the
former, there is some evidence to suggest that positive, negative and
disorganisation symptom clusters are predictive of diﬀerences in clin-
ical course and outcome (Allardyce et al., 2007a; Austin et al., 2013).
Further, they may be associated with distinct neuropsychological pro-
ﬁles (Aderibigbe and Gureje, 2008; Basso et al., 1998; Liddle and
Morris, 1991) and partially separable patterns of structural and func-
tional brain abnormalities (Kaplan et al., 1993; Koutsouleris et al.,
2008; Mozley et al., 1994; Schröder et al., 1995; Zhang et al., 2015).
However, components extracted at a ﬁner grain of analysis, e.g. the
delusions, bizarre behaviour and social dysfunction to emerge from the
ﬁrst-order symptom level analysis, may also show unique patterns of
association with deﬁned risk factors and treatment outcomes; see
Bentall et al. (2012) for example. Further research is needed therefore,
to determine which items and symptom clusters embedded in com-
monly used symptom measurement tools correlate/predict other para-
meters that are of genuine importance to our understanding of psy-
chosis, and conversely, which items/clusters should be omitted from
these measures.
In this regard it is worth noting that, to date, no formal assessment
of the relative validity (e.g. discriminant validity or predictive validity)
of higher-order versus lower-order factors has been undertaken.
Irrespective, it would seem essential that this question be addressed if
dimensional systems of classiﬁcation are to be adopted more widely in
clinical and research practice (Morris and Cuthbert, 2012; Parker,
2014). In seeking to validate diﬀerent models, however, it would be a
mistake to assume that all dimensions extracted necessarily reﬂect
mechanisms that reside at a single, common level. Returning to the
example above, whilst it might be possible to link delusions to deﬁned
neurobiological substrates, hypothetically, one might ﬁnd that other
symptoms, e.g. social dysfunction, show much less speciﬁcity in their
association; instead they might relate to multiple factors and processes
operating at distinct levels, e.g. dysfunction within deﬁned cortical
networks underpinning social cognition, but also, behavioural, inter-
personal –and potentially even sociological- processes. Hence, in vali-
dating distinct models of symptoms it will be important to seek their
correlates at multiple levels (from the neurophysiological to the social),
whilst paying close attention to the meaning of extracted dimensions
alongside their statistical properties.
4.4. Implications and future research
Within the ﬁelds of psychosis research (Morris and Cuthbert, 2012),
classiﬁcation (American Psychiatric Association, 2013; Parker, 2014)
and clinical practice (The British Psychological Society, 2014), it has
been argued that the current system of nosology is far from optimal,
and that a shift towards a dimensional model would be beneﬁcial.
However, it is arguable that such a shift would only be fruitful and
meaningful to the extent that the dimensional system adopted is robust,
e.g. reliable and valid across broad variations in age, gender, ethnicity,
culture, diagnosis, stage of illness, duration without treatment and
methods of administration; see Anderson et al. (2017), Rabinowitz et al.
(2017) and Lehoux et al. (2009) for example.
Future studies are therefore needed to explore the extent to which
symptom models vary (or remain consistent) across diﬀerent popula-
tion samples. The results reported here, however, suggest that diﬀer-
ences in statistical methodology may also contribute to variations in
ﬁndings across studies; see Peralta and Cuesta (2001) and Toomey et al.
(1997). In order to distinguish between this kind of statistical artefact
and informative ‘treatment eﬀects’, a number of approaches can be
employed. As a minimum, authors should make explicit the precise
analytic methods they use, as well as the reasoning behind their
choices; thus, even seemingly minor decisions such as the choice of data
factorability tests employed are likely to impact upon the ﬁndings (see
Section 3.3 for example). Ideally however, sensitivity analyses should
be undertaken (as reported here), so that the eﬀects of changing the
methodology are tested within the same data-set.
Whilst we have explored the eﬀects of varying data reduction, factor
extraction and rotation methods in a simple (uni-dimensional) model as
well as a two-tiered hierarchical model, other modelling approaches
have been used and should be explored further. For example, Bentall
and colleagues have shown that a non-hierarchical bifactor model, in
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which a single ‘general’ psychosis factor competes with ﬁve correlated
symptom factors to describe variance in symptoms scores, provides a
better ﬁt to psychotic symptoms than uni-dimensional or two-tiered
hierarchical models of the kind tested here and commonly found in the
literature. Further, this held true for patients with diagnoses of aﬀective
and non-aﬀective psychosis, as well as participants from the general
population (Reininghaus et al., 2016, 2013; Shevlin et al., 2017). To
facilitate such comparisons and foster transparency journals should
demand open-access to data; information can then be aggregated across
studies, and discrepancies due to variations in approach tested
(Gewin, 2016). It is worth noting also, that debate as to the relative
merit of diagnostic versus dimensional systems of classiﬁcation, as well
as the validity of hierarchical versus non-hierarchical (e.g. bifactor)
models of mental health diﬃculties, is not restricted to the study of
psychosis, but is mirrored in more general models of psychopathology
also; see Lahey et al. (2018) and Kotov et al. (2018) for discussion.
Consequently, the ﬁndings reported here may have broader relevance
outside the ﬁeld of psychosis. To test this however, future studies that
integrate data from across multiple diagnostic categories are needed in
addition to in-depth meta-analyses/systematic reviews of the ﬁeld; see
Waszczuk et al. (2017) for example.
Finally, basic data reduction approaches of this kind should also be
used in conjunction with a broad array of functional, clinical, cognitive,
neuropsychological, psychosocial and environmental indices, in order
to determine the neurobiological and etiological underpinnings (or
otherwise) of derived models, as well as their clinical and prognostic
utility. It is likely that multi-disciplinary research of this kind will
deepen our understanding of how psychosis symptoms emerge and are
maintained, and hence, lend itself to the development of novel treat-
ments and interventions that target speciﬁc symptoms or symptoms
clusters; see, for example, Pontillo et al. (2016), Freeman and Garety
(2006) and Remington et al. (2016).
4.5. Limitations
There are a number of potential limitations to this study. First, due
to a lack of correlation with other variables a number of items were
excluded from the ﬁrst-order symptom level analyses. Whilst this ap-
proach was methodologically sound, one of the symptoms to be dis-
carded was persecutory delusions, one of the most commonly reported
in psychosis. It is not clear why this was the case; however, the ex-
clusion of this symptom should be considered in future analyses of these
data and/or use of the statistical models generated (see Supplementary
Table 1). For example, it may limit the extent to which extracted
components would be expected to correlate with other variables com-
monly associated with paranoia, e.g. measures of attributional biases
(Bentall et al., 2001).
Second, the study only explored the structure of the SAPS and SANS,
symptom measures that do not include items relating to mood disorder.
As a result, the ﬁndings reported are limited in the extent to which they
can be compared directly to other common psychosis symptom mea-
sures that include a more comprehensive list of items, e.g. the PANSS
(Kay et al., 1987) and operational criteria checklist for psychotic ill-
nesses (OCCPI: McGuﬃn et al., 1991). Thus, PCA/EFA of PANSS and
OCCPI ratings typically render a ﬁve-factor solution that includes manic
and depressive symptom dimensions (van der Gaag et al., 2006;
Wallwork et al., 2012) in addition to the classic triad of symptoms
(Peralta and Cuesta, 2001). Whilst this does not challenge the robust-
ness of the positive, negative and disorganisation symptoms as a core
underlying structure, it does suggest that the triadic syndrome model
(underlying the SAPS/SANS for example) may not capture the full
range of symptoms associated with psychotic illness. However, it is
worth noting that despite diﬀerences in their design, symptom mea-
sures such as the PANSS and SAPS/SANS have still been found to
converge; see van Erp et al. (2014) for example.
With respect to data gathering, one potential limitation that was
raised by a reviewer is that participants recruited to the study were
diagnosed by nurses rather than a psychiatrist or clinical psychologist.
However, as mentioned in the Methods section, these were psychiatric
research nurses who were extremely experienced in their ﬁeld and
trained to a high level in the administration of all relevant screening,
diagnostic and symptom measurement tools. Further, and critically,
they showed high inter-rater reliability on the SAPS and SANS.
Another limitation to the study is the possible confounding eﬀects of
medication. Thus, it is unclear whether the ﬁndings reported would be
diﬀerent in patients with no history of exposure to medication.
Although individuals were excluded from the study if they had been
taking antipsychotics for more than 12 weeks, a number of reviews
have in fact shown eﬀects on symptoms, e.g. insight (Mattila et al.,
2017), after a considerably shorter period of medication use
(Agid et al., 2006). However, it is worth noting that the core triadic
syndrome structure has been demonstrated across a wide range of
studies including patients with recent-onset as well as chronic psychotic
illness, patient samples that are likely to have varied considerably with
regards to medication history (Peralta and Cuesta, 2001). Further,
follow-up/longitudinal studies suggest that whilst at the level of the
individual symptom dimension scores may shift with time (i.e.
symptom severity may shift) (Dragioti et al., 2017; Edgar et al., 2014),
within a patient sample the core symptom structure remains relatively
robust (Reichenberg et al., 2005), presumably despite an accumulating
history of medication use. Nonetheless, we cannot rule out the possi-
bility that the ﬁndings reported may have diﬀered if characteristics of
the population sample tested had diﬀered considerably, e.g. with re-
spect to medication history and/or DUP.
Finally, at a methodological level, it is worth noting that all di-
mension reduction approaches used here (i.e. variants of the EFA and
PCA) are based on Pearson's correlation matrices. Whilst, to the au-
thors’ knowledge this reﬂects the full range of approaches that have
been used to analyse the structure of psychotic symptoms in the extant
literature, Pearson's correlation matrices are in fact intended for use
with interval or ratio data, which cannot be assumed with self-report
Lickert scales such as the SAPS and SANS; nonetheless, this is common
practice within the biological and social sciences (Gilley and
Uhlig, 1993). Thus, whilst analyses included in this study were limited
to basic EFA and PCA (in line with the stated aim of exploring how
commonly reported statistical practices may have shaped discrepancies
in the extant literature), future studies should examine the impact of
using alternative data reduction approaches that do not rely on corre-
lation matrices that assume normality. Thus, it is possible that the use of
an alternative correlation matrix, e.g. one based on Spearman‘s rank
correlation coeﬃcients, would further change the pattern of ﬁndings to
emerge.
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